Skip to main content
. 2018 May 8;27(3):520–530. doi: 10.1177/0963689717753186

Fig. 5.

Fig. 5.

Human peripheral blood mononuclear cells (PBMNCs) express CD31 antigen at 14 d after injection. (A–C) Immunofluorescent imaging of the quality and quantity control (QQc) PBMNCs group 48 h after ischemia/reperfusion injury (IRI). (D–F) Immunofluorescent imaging of the QQc PBMNCs group 14 d after IRI. (A) and (D) show fluorescein isothiocyanate imaging, (B) and (E) show Texas-red imaging (anti-mouse CD31), and (C) and (F) show merged images. Arrows indicate PKH-labeled PBMNCs. The QQc PBMNCs did not express mouse CD31 antigen at 48 h (C). However, homed human QQc PBMNCs in the kidney 14 d after IRI (arrow) show anti-CD31 antigen (F).